Sources | Names Used |
---|---|
CTRPv2 | BRD-K16147474 |
PharmacoGx | BRD-K16147474 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | OLA1 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
mRNA | RP11-226E21.4 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |
mRNA | FBXO36 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
mRNA | ARHGAP30 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.02 |
mRNA | RTN4R | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
mRNA | FLII | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
mRNA | BSPRY | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
mRNA | DTYMK | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
mRNA | CYB5R4 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
mRNA | FGD4 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |